Predictive Factors for Resistant Disease with Medical/Radiologic/Liver-Directed Anti-Tumor Treatments in Patients with Advanced Pancreatic Neuroendocrine Neoplasms: Recent Advances and Controversies

SIMPLE SUMMARY: Tumor resistance, both primary and acquired, is leading to increased complexity in the nonsurgical treatment of patients with advanced panNENs, which would be greatly helped by reliable prognostic/predictive factors. The importance in identifying resistance is being contributed to by...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Lingaku, Ramos-Alvarez, Irene, Jensen, Robert T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909561/
https://www.ncbi.nlm.nih.gov/pubmed/35267558
http://dx.doi.org/10.3390/cancers14051250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909561/
https://www.ncbi.nlm.nih.gov/pubmed/35267558
http://dx.doi.org/10.3390/cancers14051250

Ejemplares similares